Add the specialty areas of your choice to tailor excemed.org to your professional interests.
Save & Create free account
No thanks, just apply selection
I already have an account. Login

User login

We offer our registered users tailored information, free online courses and exclusive content.

Can't find your password?
Reset it here.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

The Europe-Cuba Diabetic Network – Webinar 2: Severe diabetic foot ulcers: the deep wound in the diabetes soul

The Europe-Cuba Diabetic Network – Webinar 2: Severe diabetic foot ulcers: the deep wound in the diabetes soul
  • Endocrinology and metabolism
  • Diabetes
Webinar
Tuesday, Nov 23 2021

Introduction

The “Europe-Cuba Diabetes Network” proposed by EXCEMED is as a unique opportunity to build a multidisciplinary partnership for scientific and cultural exchange between Europe - a leader in research and pharmacotherapy in diabetes - and Cuba - an historically isolated country which has emerged as a Latin American of excellence in diabetes care despite the paradigm of low-care in low-income countries.

The treatment of severe ulcers in diabetic foot is an area of active and successful research in Cuba. The nerve damage, and the vascular complications observed in people with diabetes mellitus, increases the risk of foot ulcerations, infections and amputation. The risk of amputation that is faced by people with diabetes can be more than 25 times greater than that in people without diabetes. However, with good management a large proportion of amputations can be avoided.

Providing effective treatment of severe diabetic foot ulcers remains a major challenge. In fact, severe diabetic foot care is still considered an unmet medical need affecting around 6.3% of people with diabetes globally, and is among the most invalidating complications of diabetes. Thus, novel therapeutical approaches are needed.

BioCubaFarma's Heberprot-P demonstrated a reduction in amputations due to DFU by 78%.  Nevertheless, although approved in Europe since 2017, no recommendation is present in the IWGDF guidelines (2019 update) for the use of intralesional EGF. This suggests that further collaborative research and discussion about the pros and cons of such an approach is needed. Therefore, a scientific collaboration between Europe and Cuba is needed to promote further research on this hot topic.

Learning objectives

At the end of the event, attendees are expected to:

  • Increase the awareness about the burden of diabetic foot worldwide
  • Deepen the causes of differences in the prevalence and severity of diabetic foot between Cuba and Europe
  • Learn about the most recent developments in terms of advanced wound care technologies for diabetic foot ulcers  
  • Learn about mechanism of action and efficacy of Heberprot-P

Scientific programme

AGENDA - Webinar II - November 23, 2021 - 16:00 to 18:30 CET

 

16:00-16:15        Welcome and introduction

Paolo Pozzilli (Italy)

 

Session I - Diabetic foot: how deep is this wound in the diabetes world?

 

16:15-16:35        L1 - Global impact of diabetic foot  

Nebojsa M. Lalic (Serbia)

 

16:35-16:55        L2 - Risk of severe diabetic foot ulcers in Cuba

Manuel R. Raíces Pérez-Castañeda (Cuba)

 

16:55-17:10        Q&A

 

Session II - The new era of diabetic foot management: will we heal the deep wound?

 

17:10-17:30        L3 - Advanced wound care technologies: when standards of care are not enough

Roberto Da Ros (Italy)

 

17:30-17:50        L4 - Severe ulcers in diabetic foot: the Cuban approach

Manuel R. Raíces Pérez-Castañeda (Cuba)

 

17:50-18:05        Q&A

 

18:05-18:30        Wrap-up and next steps

 

18:30                     End of the webinar

Chair(s)

Paolo Pozzilli

Endocrinology and metabolic diseases Department
University Campus Bio-Medico di Roma (UCBM)
Rome, Italy
Speakers

Paolo Pozzilli

Endocrinology and metabolic diseases Department
University Campus Bio-Medico di Roma (UCBM)
Rome, Italy

Nebojsa M. Lalic

Clinic for Endocrinology, Diabetes and Metabolic Diseases
University of Belgrade
Serbia

Roberto Da Ros

Gruppo di studio della Podopatia diabetica SID-AMD
Italy
Slide kit
Nebojsa M. Lalic
Endocrinology and metabolism
Slide kit
Manuel R. Raíces Pérez-Castañeda
Endocrinology and metabolism

Video
Manuel R. Raíces Pérez-Castañeda
Endocrinology and metabolism
Slide kit
Manuel R. Raíces Pérez-Castañeda
Endocrinology and metabolism